From: Cost-effectiveness analysis on COVID-19 surveillance strategy of large-scale sports competition
Parameter | Value | Value range |
---|---|---|
Initial infections rate (IIR) | 0.020 [25] | 0.001–0.020 |
\(\lambda\) | 6.258 [26] | – |
\(k\) | 2.543 [26] | – |
\(\gamma\) | – | |
\(\mu\) | 0.92 [30] | 0.69–1.00 |
\({\rho }_{1}\) | 0.33 [31] | 0.20–0.90 |
Infectious period (IP) | 6.00–20.00 | |
Vaccination rate (\({P}_{v}\)) | 0.58 [33] | 0.20–1.00 |
Efficacy against infection (\({P}_{i}\)) | 0.39 [34] | 0.10–0.60 |
Efficacy against symptom (\({P}_{s}\)) | 0.84 [35] | 0.50–1.00 |
Basic reproductive number (\({R}_{0}\)) | 3.38 [36] | 2.54–12.00 |